Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
5.82
-0.15 (-2.51%)
At close: Sep 15, 2026, 4:00 PM EDT
5.76
-0.06 (-1.03%)
After-hours: Sep 15, 2026, 5:32 PM EDT

Opus Genetics Revenue

Opus Genetics had revenue of $755.00K in the quarter ending June 30, 2026, a decrease of -73.80%. This brings the company's revenue in the last twelve months to $9.86M, down -36.09% year-over-year. In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth.

Revenue (ttm)
$9.86M
Revenue Growth
-36.09%
P/S Ratio
49.30
Revenue / Employee
$352,000
Employees
28
Market Cap
484.20M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Puma Biotechnology231.24M
Autolus Therapeutics117.39M
ARS Pharmaceuticals116.93M
Prelude Therapeutics22.42M
Capricor Therapeutics11.13M
Ovid Therapeutics1.58M
Artiva Biotherapeutics251.00K
Entera Bio42.00K
Revenue Rankings

IRD News

More News